Intermittent use of pantoprazole and famotidine in severe hypomagnesaemia due to omeprazole.

Fernández-Fernández, F J; Sesma, P; Caínzos-Romero, T; Ferreira-González, L

Fernández-Fernández, F J; Sesma, P; Caínzos-Romero, T; Ferreira-González, L.

Affiliation

Fernández-Fernández FJ; Department of Internal Medicine, Hospital Arquitecto Marcide, Ferrol, Spain. fjf-fernandez@terra.es

Neth J Med ; 68(10): 329-30, 2010 Oct.

Article in En | MEDLINE | ID: mdl-21071783

Subject(s)

2-Pyridinylmethylsulfinylbenzimidazoles/administration & dosage; Anti-Ulcer Agents/administration & dosage; Famotidine/administration & dosage; Magnesium Deficiency/chemically induced; Omeprazole/adverse effects; Proton Pump Inhibitors/adverse effects; Aged; Anti-Ulcer Agents/adverse effects; Histamine H2 Antagonists/administration & dosage; Humans; Magnesium Deficiency/blood; Magnesium Deficiency/drug therapy; Male; Pantoprazole; Proton Pump Inhibitors/administration & dosage; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Omeprazole / Famotidine / 2-Pyridinylmethylsulfinylbenzimidazoles / Proton Pump Inhibitors / Magnesium Deficiency / Anti-Ulcer Agents Limits: Aged / Humans / Male Language: En Journal: Neth J Med Year: 2010 Document type: Article Affiliation country: Spain

Search on Google

Add to My VHL

XML

PubMed Links